| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11910-012-0256-9 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1007/s11910-012-0256-9 |
| P932 | PMC publication ID | 3463137 |
| P698 | PubMed publication ID | 22354545 |
| P5875 | ResearchGate publication ID | 221851385 |
| P2093 | author name string | Raymond S Douglas | |
| Terry J Smith | |||
| Erin F Gillespie | |||
| P2860 | cites work | Update on colchicine and its mechanism of action | Q28217460 |
| Selenium and the course of mild Graves' orbitopathy | Q28238021 | ||
| Usefulness of colchicine in preventing recurrences of pericarditis | Q28253583 | ||
| Development of criteria for evaluating clinical response in thyroid eye disease using a modified Delphi technique | Q30413598 | ||
| Rituximab treatment of patients with severe, corticosteroid-resistant thyroid-associated ophthalmopathy | Q33624477 | ||
| Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach | Q33647383 | ||
| Smoking and thyroid disorders--a meta-analysis | Q33845621 | ||
| Management of Graves' ophthalmopathy: reality and perspectives | Q33899550 | ||
| Long-term results of irradiation for patients with progressive Graves' ophthalmopathy | Q34430156 | ||
| Rituximab: mechanism of action and resistance | Q34528335 | ||
| Development of a disease specific quality of life questionnaire for patients with Graves' ophthalmopathy: the GO-QOL. | Q35305938 | ||
| Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy | Q74010201 | ||
| A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy | Q74459180 | ||
| Cigarette smoking and treatment outcomes in Graves ophthalmopathy | Q77458223 | ||
| Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study | Q79546631 | ||
| Colchicine in the treatment of the inflammatory phase of Graves' ophthalmopathy: a prospective and randomized trial with prednisone | Q79712503 | ||
| Slow-release lanreotide in Graves' ophthalmopathy: A double-blind randomized, placebo-controlled clinical trial | Q79775301 | ||
| Determinants of liver damage associated with intravenous methylprednisolone pulse therapy in Graves' ophthalmopathy | Q80231750 | ||
| Randomized, double-blind, placebo-controlled trial of long-acting release octreotide for treatment of Graves' ophthalmopathy | Q80293192 | ||
| The effect of etanercept on Graves' ophthalmopathy: a pilot study | Q81024281 | ||
| Efficacy of rituximab treatment for thyroid-associated ophthalmopathy as a result of intraorbital B-cell depletion in one patient unresponsive to steroid immunosuppression | Q82927501 | ||
| Pharmacotherapy: does selenium supplementation improve Graves ophthalmopathy? | Q84639505 | ||
| Selenium and the course of mild Graves' orbitopathy | Q84816510 | ||
| Rationale for radiotherapy in thyroid eye disease | Q84939744 | ||
| Impact of smoking on the response to treatment of thyroid associated ophthalmopathy | Q35591093 | ||
| Treatment of thyroid associated ophthalmopathy with periocular injections of triamcinolone | Q35592595 | ||
| Effects of Graves' ophthalmopathy on quality of life | Q35785147 | ||
| Relationship between cigarette smoking and Graves' ophthalmopathy | Q35785152 | ||
| Cigarette smoking and thyroid eye disease: a systematic review | Q36596473 | ||
| Efficacy of corticosteroids and external beam radiation in the management of moderate to severe thyroid eye disease | Q36951664 | ||
| Orbital radiation for graves ophthalmopathy: a report by the American Academy of Ophthalmology | Q37033302 | ||
| Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy | Q37110191 | ||
| Clinical practice. Graves' ophthalmopathy | Q37407540 | ||
| Treatment modalities for Graves' ophthalmopathy: systematic review and metaanalysis | Q37505761 | ||
| Somatostatin receptor gene expression and inhibitory effects of octreotide on primary cultures of orbital fibroblasts from Graves' ophthalmopathy | Q38310069 | ||
| A long-term follow-up study after retro-orbital irradiation for Graves' ophthalmopathy | Q38490904 | ||
| Systemic adverse events following rituximab therapy in patients with Graves' disease. | Q40340279 | ||
| Plasma filtration in the treatment of Graves' ophthalmopathy: A randomized study. | Q42476684 | ||
| Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts | Q42641036 | ||
| Orbital steroid injection versus oral steroid therapy in management of thyroid-related ophthalmopathy | Q43055601 | ||
| High-dose intravenous corticosteroid therapy for Graves' ophthalmopathy | Q43583587 | ||
| Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study | Q43705603 | ||
| Temporal relationship between onset of Graves' ophthalmopathy and onset of thyroidal Graves' disease | Q43758895 | ||
| Long-term safety of orbital radiotherapy for Graves' ophthalmopathy | Q44547490 | ||
| Orbital irradiation for Graves' ophthalmopathy: Is it safe? A long-term follow-up study | Q45003668 | ||
| Octreotide (long-acting release formulation) treatment in patients with graves' orbitopathy: clinical results of a four-month, randomized, placebo-controlled, double-blind study | Q45161391 | ||
| Double-blind, placebo-controlled trial of octreotide long-acting repeatable (LAR) in thyroid-associated ophthalmopathy. | Q45173583 | ||
| Rituximab for thyroid eye disease | Q46542384 | ||
| Randomized, single blind trial of intravenous versus oral steroid monotherapy in Graves' orbitopathy | Q46585048 | ||
| Surgical or medical decompression as a first-line treatment of optic neuropathy in Graves' ophthalmopathy? A randomized controlled trial | Q46665485 | ||
| Multi-center study on the characteristics and treatment strategies of patients with Graves' orbitopathy: the first European Group on Graves' Orbitopathy experience | Q47945181 | ||
| Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy. | Q50933902 | ||
| Intravenous immunoglobulin versus corticosteroid in treatment of Graves' ophthalmopathy. | Q50935701 | ||
| Colchicine versus placebo in Behçet's disease: randomized, double-blind, controlled crossover trial. | Q53190954 | ||
| A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild Graves' ophthalmopathy. | Q53359335 | ||
| Comparison of intravenous methylprednisolone therapy vs. oral methylprednisolone therapy in patients with Graves' ophthalmopathy. | Q53758474 | ||
| Supervoltage orbital radiotherapy for Graves' ophthalmopathy | Q67249584 | ||
| Effect of Abnormal Thyroid Function on the Severity of Graves' Ophthalmopathy | Q67657511 | ||
| Orbital cobalt irradiation combined with retrobulbar or systemic corticosteroids for Graves' ophthalmopathy: a comparative study | Q68187821 | ||
| Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathy | Q69288448 | ||
| Methylprednisolone in the treatment of exophthalmos | Q70064786 | ||
| Orbital Cobalt Irradiation Combined with Systemic Corticosteroids for Graves' Ophthalmopathy: Comparison with Systemic Corticosteroids Alone* | Q70251349 | ||
| Ciclosporin and prednisone v. prednisone in treatment of Graves' ophthalmopathy: a controlled, randomized and prospective study | Q70321449 | ||
| Evidence of adipocyte differentiation in human orbital fibroblasts in primary culture | Q71477264 | ||
| Randomized trial of intravenous immunoglobulins versus prednisolone in Graves' ophthalmopathy | Q71778725 | ||
| Smoking and endocrine ophthalmopathy: impact of smoking severity and current vs lifetime cigarette consumption | Q71871480 | ||
| Does early administration of thyroxine reduce the development of Graves' ophthalmopathy after radioiodine treatment? | Q72414211 | ||
| Cigarette smoking and risk of clinically overt thyroid disease: a population-based twin case-control study | Q73563750 | ||
| Radiotherapy for Graves' orbitopathy: randomised placebo-controlled study | Q73761107 | ||
| P433 | issue | 3 | |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 318-324 | |
| P577 | publication date | 2012-06-01 | |
| P1433 | published in | Current Neurology and Neuroscience Reports | Q18206211 |
| P1476 | title | Thyroid eye disease: towards an evidence base for treatment in the 21st century | |
| P478 | volume | 12 |
| Q40095263 | Dysthyroid optic neuropathy: update on pathogenesis, diagnosis, and management |
| Q94554835 | Etiologies of Proptosis: A review |
| Q59329543 | Intraoperative relaxed muscle positioning technique results in a tertiary Center for Thyroid Orbitopathy Related Strabismus |
| Q37729442 | Selenium supplementation in thyroid associated ophthalmopathy: an update |
| Q37106711 | Short and long-term effects of high-dose intravenous methylprednisolone pulse therapy on thyroid-associated ophthalmopathy |
| Q91789199 | Thyroid Eye Disease: How A Novel Therapy May Change The Treatment Paradigm |
Search more.